Unknown

Dataset Information

Role of circulating tumor DNA in early-stage triple-negative breast cancer: a systematic review and meta-analysis.


ABSTRACT:

Background

Triple-negative breast cancer (TNBC) accounts for 15% of all breast cancers and carries a worse prognosis relative to other breast cancer subtypes. This systematic review and meta-analysis evaluated the prognostic value of circulating tumor DNA (ctDNA) in early-stage TNBC.

Methods

A literature search was conducted using Ovid Medline, Elsevier EMBASE, Cochrane Central Register of Controlled Trials, and Web of Science Databases for publications up to 11/16/2023. Results were uploaded to Covidence and assessed by two independent reviewers. Studies assessing the use of ctDNA to predict recurrence free survival and related outcomes as well as overall survival were included. All recurrence outcomes were combined during analysis. Statistical analysis was performed using

SUBMITTER: Zhang D 

PROVIDER: S-EPMC11905660 | biostudies-literature | 2025 Mar

REPOSITORIES: biostudies-literature